
The Australian share market edged slightly higher this week, with the ASX 200 finishing up 0.2%. A rebound in resource stocks helped offset weakness across most other sectors. Healthcare was among the hardest hit, with CSL pressured by uncertainty around the latest round of pharmaceutical tariffs announced in the US. Inflation remains a key focus, with August CPI rising to 3% year-on-year, largely due to a 25% jump in electricity costs as state rebates expired. With price pressures still sticky, the RBA is widely expected to keep interest rates on hold at its September meeting.
Read Post








